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Abstract
Positron emission tomography, single photon emission computed tomography and planar projection imaging of radioactive tracers have
long been in use for detecting and diagnosing disease in human subjects. More recently, advanced versions of these same technologies have
begun to be used across the breadth of modern biomedical research to study non invasively small laboratory animals in a myriad of
experimental settings. In this report, we describe some of the new instruments and techniques that make these measurements possible
and illustrate, with a few examples, the potential power of these methods in modern biomedical research. Published by Elsevier Science Ltd.
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1. Introduction
In vivo imaging of pharmaceuticals labeled with radio-
nuclides has proven to be a powerful diagnostic tool in
human subjects. Important applications of this technology
can be found in oncology, neurology, cardiology and
virtually every other medical discipline. Indeed, over the
years, these same imaging methods have often been applied
in small animals, but usually only within the nuclear medi-
cine (NM) community, and usually only to evaluate the
ef®cacy of new radiopharmaceuticals.
During the past 5 years or so, this situation has begun to
change, not only in NM, but also across most of the other
imaging modalities. In the case of NM, it has gradually been
realized that with the right imaging equipment and radio-
pharmaceutical infrastructure, the entire NM armamentar-
ium can be brought to bear in small animals to solve a host
of experimental problems that emerge from contemporary
biomedical research. Among the areas of greatest promise
are applications in drug discovery and development [1], in
the study of small animal models of human diseases, and in
characterizing gene expression and phenotype changes that
arise from genetic manipulations [2]. In order to carry out
such studies successfully, however, imaging systems must
be available that meet the demanding spatial resolution and
sensitivity requirements imposed when imaging subjects
thousands of times less massive than humans. Human NM
scanners do not, in general, meet these requirements except
under certain very specialized circumstances and so cannot
be used for this purpose. Instead, a number of laboratories
world-wide have embarked on the development of imaging
systems tailored speci®cally to small animal imaging
[3 13]. In many cases, this work has yielded devices with
certain performance characteristics substantially better than
commercial human scanners [11,13], and has laid the foun-
dation for the widespread use of NM techniques outside the
NM community. In this report, we describe the general
features of several of these devices and several applications
that illustrate their use. First, however, we note some of the
factors that distinguish small animal imaging studies from
their human counterpart.
2. The small animal imaging environment
Mice and rats used in typical small animal studies weigh
between 20 30 and 200 300 g, respectively. The ªstandard
manº, on the other hand, weighs 70,000 g, several thousand
times more than a mouse and several hundred times more than
a rat. In round numbers, the linear dimensions of organs in
these animals are 10 or more times smaller in each dimension
than in human subjects. It follows, therefore, that if imaging
studies in these animals are to be ªequivalentº to human
studies, the spatial resolution of an animal scanner must be
about 10 (or more) times better than a human scanner.
ªEquivalentº in this context means that the animal organ is
visualized on the animal scale with the same relative acuity as
the human organ is imaged on the human scale. The ®rst
challenge, therefore, is to improve spatial resolution by a
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very large factor relative to human scanners (.10), or in abso-
lute terms, to a fraction of a millimeter.
The large difference in body mass between small animals
and human subjects also introduces another potential compli-
cation: the effects of speci®c activity of the radiopharmaceu-
tical (the amount of radioactivity per unit mass of drug).
Contrary to intuition, high resolution imaging of small animals
cannot be performed with tracer doses scaled downward in the
ratio of animal to human body masses. Indeed, it can be shown
that, to a ®rst approximation, the same absolute amount of
radioactivity must be used in both subjects. The reason for
this is that the size of the resolution ªvoxelº appropriate to
the mouse or rat scales with the mass of the animal. If the
statistical precision of measurement of activity in that voxel
is to be the same as in the equivalent human study, the same
absolute amount of radioactivity must be delivered to the small
animal voxel. This requirement, in turn, implies that the same
absolute amount of drug must be given to the animal as to the
human, since it is the drug that carries the radioactivity to that
voxel. However, if a human dose is given to an animal, the
concentration of drug in the animal may be thousands of time
greater than in the human since the animal is thousands of
times less massive. The possibility exists, therefore, that
such large concentrations could, in some cases, cause pharma-
cological effects in small animals rather than act as tracers, e.g.
when attempting to label low concentrations of receptors in the
brain. It can be shown semi-quantitatively that this ªspeci®c
activityº problem can be minimized by formulating radiophar-
maceuticals with speci®c activities much higher than for
human subjects and by increasing the sensitivity of the
imaging device by a substantial factor. Fortunately, both of
these avenues can be pursued in the context of small animal
imaging.
Finally, a third set of issues must be considered when
imaging small animals that are not often encountered
when imaging human subjects: complications involving
tracer administration, blood sampling, movement suppres-
sion and anesthesia, and maintenance of the animal during
the imaging process.
All NM studies require administration of a tracer directed
toward some particular target. Routes of administration
include intravenous, intra-arterial, intra-peritoneal, intra-
muscular, oral, direct installation and inhalation. The size
of these animals, however, presents signi®cant challenges
when the tracer must be administered directly into the circu-
lation by vein or artery (often the most favored routes).
Veins and arteries in mice and rats are small in diameter
making such injections dif®cult. Similar dif®culties are also
encountered when blood samples must be drawn from veins
or arteries for metabolite assays or for de®ning the tracer
input function to an organ. In addition, the total volume of
tracer injected or blood withdrawn must be kept small
compared to the animal's blood volume to avoid compro-
mising the animal's circulatory status.
Another important difference between human and small
animal studies lies in the need to actively suppress move-
ment of the animal during imaging. While most human
subjects can remain relatively motionless, small animals
must be restrained or placed under anesthesia. Both of
these strategies potentially interfere with studies in which
the time course of radioactivity through various organ
systems is to be studied. Anesthetics often alter heart rate
and respiration and can, in some cases, directly interfere
with tracer uptake. Restraint without anesthesia can also
alter the animal's metabolic status. This combination of
factors can thus potentially distort the true time variation
of tracer uptake that might be observed if the animal were in
its natural state. Moreover, given the small size of structures
being observed at high resolution, normal respiratory and
cardiac movements could cause blurring of the acquired
image data. These sub-millimeter/millimeter scale move-
ments might, therefore, also have to be arti®cially controlled
or otherwise countered by cardiac and respiratory gating.
Small animals also differ from human subjects in the level
of maintenance required during an imaging study. For
example, small animals possess a much larger body surface
area to body mass ratio than human subjects and so lose heat
much more readily. As a result, the animal's body tempera-
ture must be monitored and maintained arti®cially during
extended imaging studies. Circulating warm water blankets,
circulating warm air, heat lamps and other schemes have all
been used for this purpose. In addition to monitoring body
temperature, it has become increasingly common to record
the animal's ECG signal, control respiratory rate through
mechanical ventilation, measure and record blood gas levels
and other important physiological variables. Such record
keeping and control of the animal's metabolic state can
signi®cantly reduce inter-animal variability and greatly aid
in the interpretation of the acquired image data.
As suggested above, substantial differences exist between
imaging studies in humans and small animals that must be
addressed if small animal studies are to be carried out
successfully. These differences present, in many cases,
signi®cant challenges in their own right and not all of the
problems alluded to above have been solved. Since many of
these same problems arise in other imaging modalities, e.g.
MR, CT, it may be that solutions found in one area can be
directly adapted to the NM environment and vice versa.
Assuming that an animal can be properly prepared and
maintained, the animal must be imaged by a device with
suf®cient spatial resolution and sensitivity to accomplish the
prescribed imaging task. In the remainder of this report, we
examine some of the factors that affect spatial resolution and
sensitivity of PET, SPECT and planar imaging systems now
in use to image small animals.
3. PET imaging
Resolution and sensitivity in small animal PET are
limited by three important factors: (1) positron range; (2)
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non-collinear annihilation; and (3) the intrinsic spatial reso-
lution and sensitivity of the imaging system.
Positron emission tomography (PET) relies on coinci-
dence detection of paired 511 keV photons generated
when an emitted positron and a nearby electron totally anni-
hilate one another. Spatial resolution in PET is in¯uenced by
this process since the positron travels some distance away
from the disintegrating nucleus before encountering the
electron. This distance, the ªpositron rangeº, represents a
built-in ªblurº present in all PET images that depends on the
kinetic energy imparted to the positron during decay. The
higher this ªendpointº energy, the farther the positron will
generally travel and the worse the blur. While this effect is
usually small compared to other factors in human imaging,
instruments with high intrinsic spatial resolution can be
adversely affected depending on the positron-emitting
isotope. Fluorine-18, for example, possesses a short positron
range (fraction of a millimeter) that is small compared to the
intrinsic resolution of the ®rst generation of dedicated small
animal scanners (about 1 2 mm, [6,7,10 12]). Images of
compounds labeled with this isotope, e.g. 2-¯uoro-2-deoxy-
glucose, are thus only marginally degraded by positron
range. Other positron-emitters such as O-15, N-13, Tc-
94 m and I-124, however, possess higher endpoint energies
and greater ranges and can give rise to measurable image
degradation even in ®rst generation machines. This problem
will be of much greater signi®cance in second generation,
1-mm scanners where the positron range of almost all
commonly available positron-emitters will be comparable
to the system resolution.
Another source of image blur arises from non-collinear
annihilation events. In such cases, positron/electron annihi-
lation does not give rise to two 511 keV photons moving
away from each other along a straight line, as is assumed,
but rather along two lines at slight angles with respect to one
another. Image blur associated with this effect increases as
detector separation increases, but can potentially be mini-
mized in small animal imaging systems by reducing detec-
tor separation to a distance commensurate with the size of
the animal. Reducing detector separation also has the bene-
®cial effect of increasing the geometric detection sensitivity
of the imaging system. Unfortunately, there is a limit to this
strategy. As detector separation decreases, the so-called
ªdepth-of-interactionº (DOI) effect becomes important.
This effect results in an increased uncertainty in the location
of the endpoints of lines-of-response connecting detector
pairs. This uncertainty, in turn, causes spatial resolution to
degrade. In ring-type scanners, DOI manifests itself as an
increasing reduction in spatial resolution for off-axis
sources as ring diameter shrinks. In other kinds of devices,
resolution is decreased for lines-of-response de®ned by
annihilation rays that enter the detectors at increasingly
oblique angles as detector separation is reduced. It follows,
therefore, that if the effect of non-collinear annihilation is to
be reduced, and geometric sensitivity increased, by bringing
the detectors closer together, some scheme must be devised
to counter the DOI effect. Given the other practical virtues
of reduced detector separation, e.g. smaller number of
detectors needed to surround the animal and lower cost, it
is not surprising that a number of novel methods have been
proposed to reduce the DOI error for small diameter
imaging systems. These methods include the use of multi-
layer phoswich scintillation crystal arrays in which the layer
of interaction is determined by differences in light decay
time between the scintillator in each layer [14,15], and by
locating events along a crystal by measuring the light output
from each end of the crystal [16]. It has been shown that
these schemes, which yield relatively crude estimates of
interaction depth along a crystal, can signi®cantly reduce
the DOI effect at small ring diameters and these, or other
methods, will likely be used in at least some second genera-
tion machines. It is noteworthy that an effective DOI correc-
tion capability is already present in a non-scintillator based
imaging system [11].
Although range and DOI effects are important sources of
image degradation, the design of ®rst generation, dedicated
small animal PET scanners has been dominated by the need
to signi®cantly improve the intrinsic spatial resolution of
small animal scanners relative to human scanners. Indeed,
enormous ingenuity has been shown in the development of
high-resolution instruments and it is not uncommon for the
very newest technologies to be ®rst demonstrated in animal
systems. In particular, systems are now in operation [7,13]
or being designed [17] that exploit the properties of a new
class of high-speed, high light output lutetium-based scin-
tillators. Lutetium oxyorthosilicate (LSO), for example,
possesses a scintillation ef®ciency more than ®ve times
higher than bismuth germanate (BGO), a stopping power
for 511 keV radiation only slightly less than BGO and a
light decay time shorter than BGO by more than a factor
of eight. This combination of advantages over BGO, the
scintillator in most human PET scanners, makes it possible
to: (1) reduce the cross-sectional area of individual LSO
crystals signi®cantly, thereby improving intrinsic spatial
resolution; (2) stop incident 511 keV radiation with good
ef®ciency; (3) allow much higher counting rates due to the
short light pulse duration; and (4) improve random coinci-
dence rejection.
Advanced position-sensitive phototube technology
[18,19] is also being used to identify the crystal-of-interac-
tion in arrays of such crystals. These devices possess high
speed, compact design and excellent light collection ef®-
ciency. The use of solid-state devices instead of phototubes
to read out arrays of scintillation crystals has also been ®rst
demonstrated at the system level in a small animal scanner
[6].
Alternatives to scintillator-based PET scanners have also
been explored. The novel converter plate/gas ampli®cation
imaging system devised by Jeavons et al. [11], for example,
produces extremely high resolution images [20] suggesting
that alternative technologies may offer some advantages
over conventional designs. All of these technological and
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conceptual advances have emerged from a lively, vigorous
and continuing research effort that promises even greater
improvements in instrumentation in the future.
In addition to these purely instrument-related develop-
ments, it has also been recognized that spatial resolution
can be signi®cantly improved by using iterative reconstruc-
tion methods, rather than conventional ®ltered backprojec-
tion, to process image data acquired with any of these
systems. These new algorithms provide a natural means of
ªde-blurringº the image data by incorporating a model of
the physical performance of the imaging system and, poten-
tially, positron range into the algorithm. Twenty to thirty
percent improvements in spatial resolution have been
demonstrated for these methods compared to ®ltered back-
projection. Iterative methods, however, are extremely
computationally intensive and exhibit subtle object-depen-
dent convergence properties and it remains an important
area of research to develop fast algorithms and to de®ne
cutoff criteria for properly terminating the iteration process.
The importance of this effort cannot be understated since it
is likely that the only way sub-millimeter resolution can be
achieved is by combining very high intrinsic performance
imaging systems with iterative algorithms that carefully
model the physics of the entire imaging process. Interest-
ingly, attainment of high resolution with these methods will
not only require machines with high intrinsic spatial resolu-
tion, but machines with extremely high sensitivity if image
noise is to be held low while allowing spatial resolution to
increase with iteration number. While almost all ®rst-
generation machines utilize 3D data acquisition to improve
sensitivity, the coincidence sensitivity per unit solid angle of
detector differs appreciably. Ultimately, designs with the
highest possible value of this parameter are most likely to
achieve the sub-millimeter resolution goal.
An example of a study embodying many of these resolu-
tion-enhancing advances is shown in Fig. 1. These images of
the bones in the head of a mouse were made with an experi-
mental, 1.3 mm intrinsic resolution bench-top scanner after
labeling the animal's skeleton with 18-F ¯uoride. The scan-
ner was designed speci®cally to achieve the highest possible
spatial resolution but possesses a sensitivity too low for
routine ªproductionº imaging of small animals. In order to
compensate for this low sensitivity, more than 2 h of data
collection was required for the images shown in the ®gure.
These image data were reconstructed using the iterative 3D
OSEM algorithm containing a simple Gaussian model of the
systems resolution response [21]. This imaging arrange-
ment, therefore, simulates a high intrinsic spatial resolution
scanner combined with iterative reconstruction and resolu-
tion recovery. Spatial resolution in these images is slightly
better than 1 mm with a slice thickness of 400 mm. Such
images may be obtained routinely by ªproductionº scanners
of the next generation.
Despite the various complicating factors noted in the
preceding discussion, ªproductionº small animal PET scan-
ners now in use exhibit a spatial resolution in the 1 2 mm
range [6,7,10 12], although with varying degrees of sensi-
tivity. Although this resolution is poorer than the sub-milli-
meter goal noted earlier, an enormous variety of studies can
still be carried out successfully in small animals. These
studies include (usually) dynamic and static imaging of all
the major body organs in the rat, including brain substruc-
tures. Brain imaging in mice with low contrast tracers such
as 18-F 2-¯uoro-2-deoxyglucose is limited at this resolu-
tion, but satisfactory studies of whole organs or large,
widely separated brain structures, e.g. the striatum labeled
with high af®nity receptor ligands, can be obtained when the
tracer biodistribution is favorable. PET is currently the most
advanced tracer imaging technology for small animals and
continues to be an area of intense research into all aspects of
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Fig. 1. 18 F ¯uoride coronal section images of the bones in the head of a mouse obtained with an experimental, bench top PET scanner. Images are 0.4 mm
thick and spaced 1.2 mm apart. Spatial resolution in these images is slightly better than 1 mm. Images were created using the 3D OSEM algorithm
(30 iterations) containing a model of the system resolution response. N nares, ZY left, right zygomatic arches, J left, right jawbones. Note image scale.
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the imaging process, e.g. instrumentation, image reconstruc-
tion methods, etc.
4. SPECT imaging
A signi®cant practical limitation to small animal PET
imaging is the high cost of the infrastructure required to
support this imaging modality. Short-lived PET radio-
pharmaceuticals must usually be created in an (expensive)
on-site cyclotron/radiochemistry production facility. SPECT
imaging, in contrast, can, in many cases, draw on a mature
isotope distribution network and exploit the so-called ªshake
and bakeº kits available to make a range of useful tracer
compounds in-house. SPECT studies can also be carried out
with commercially available scintillation cameras.
While SPECT possesses these desirable attributes, the
small animal imaging options available with current tech-
nology are limited. The only current method for achieving
SPECT spatial resolution in the 1 2 mm range is by using a
pinhole collimator. With this device an image of the (small)
object is projected through the pinhole onto a large area
detector such as a conventional scintillation camera. The
resulting magni®cation of the object improves the apparent
resolution of the image depending on the size of the pinhole
and other factors. Under normal circumstances, a full tomo-
graphic projection set can only be obtained by mechanically
rotating the camera around the animal or by rotating the
animal in front of the pinhole. In either case, some time is
required to acquire a full data set so that true dynamic
SPECT imaging is not possible, at least with this arrange-
ment. In addition, the sensitivity of a single pinhole is neces-
sarily low. Fortunately, when imaging small animals, the
pinhole can be located close to the animal and sensitivity
can often be comparable to other forms of single photon
collimation. However, sensitivity in conventional single
photon imaging cannot, in general, match that of PET
since image formation is always by mechanical collimation,
an inherently inef®cient process. True dynamic SPECT
imaging must await development of instruments speci®cally
designed for this purpose. It should also be noted that recon-
struction of pinhole SPECT image data requires special
reconstruction algorithms that account for the pinhole
projection geometry [22]. With such algorithms, spatial
resolution in the reconstructed images is good near the
central scanning plane but deteriorates away from the
central plane due to inconsistent spatial sampling of the
object.
Despite the limitations of existing instruments, high reso-
lution SPECT images of a variety of ªmicrosphere-likeº, or
time-stationary, tracers can now be obtained, including
those that permit visualization of regional cerebral blood
¯ow, regional myocardial perfusion and regional bone
metabolism to name just a few. As noted above, all of
these studies can be carried out with only minor modi®ca-
tions to conventional, relatively inexpensive and available,
gamma cameras. Examples of pinhole SPECT studies and a
discussion of the advantages and disadvantages of SPECT
pinhole imaging can be found in a recent review article by
Weber and Ivanovic [23].
5. Planar projection imaging
If one is willing to give up the quantitative accuracy of
tomographic imaging, single projection views of positron
and single photon emitters can be obtained at high temporal
resolution as well as high (2D) spatial resolution. Single
photon imaging can be carried out with a stationary pinhole
collimator viewing a stationary animal at a distance suf®-
cient to visualize all or part of the animal. Dynamic imaging
can be started at the moment of injection to yield a high
temporal resolution image sequence of the passage of tracer
through the body organs. The amount of single photon tracer
that can be injected is subject to the same speci®c activity
considerations noted earlier for PET radiopharmaceuticals.
Time-activity curves can be created from regions-of-interest
placed over different structures in the image sequence in
order to quantify tracer transport. Although such studies
collapse the third dimension onto a plane and thus introduce
an uncertainty due to ªbackgroundº activity in over and
underlying structures, measures can be taken to minimize
the magnitude of this error in small animals. Unlike human
studies, calibration procedures can be devised in small
animals by comparing in vivo count rates from body regions
and organs to actually measured activities of these same
structures counted in vitro. While such methods will always
be approximate when applied to different animals, they can
reduce background errors appreciably and in some cases,
may produce results comparable to the equivalent tomo-
graphic study. It is also noteworthy that these kinds of
studies do not require SPECT-capable instruments. A
conventional, and relatively inexpensive, non-SPECT
camera can perform this task (as well as small animal
SPECT if the animal is rotated in front of the stationary
camera).
While projection imaging of single photon tracers has
been in use throughout NM for many years, projection
imaging of positron emitters is relatively recent. If distribu-
tions of positron emitters are simply treated as photon
sources, they too can be imaged through appropriately
designed collimators [24]. However, the high energy of
positron annihilation photons requires choices in collimator
design that preclude use of this method in small animals.
Most of these dif®culties can be overcome by performing
projection imaging, not with collimators, but with positron
emitters imaged with a pair of specially designed scintilla-
tion cameras in time coincidence. If these cameras have a
relatively large ®eld-of-view, and if the detectors possess
high stopping power for 511 keV radiation, then all or most
of a small animal can be visualized with good sensitivity
when placed between the detectors. If now only coincidence
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events that lie along lines nearly perpendicular to both
detector faces are accepted, the activity distribution in the
animal will be projected onto one of the detectors forming a
planar image of the distribution. Such images, or image
sequences, can be analyzed using the same strategies and
calibration procedures noted above. This form of ªcollima-
tor-lessº planar projection imaging possesses the virtue, like
its single photon cousin, that it can be carried out with
relatively inexpensive equipment, yet yield a high (2D)
spatial and temporal resolution result.
An example of this kind of positron projection imaging in
a mouse is shown in Fig. 2. In order to obtain these images,
the animal was placed between two BGO scintillation
cameras in time coincidence (the ªPiPETº [12], Projection
Imager/PET). Each camera consists of an array of 22 £ 26
individual BGO crystals, each 2 mm £ 2 mm £ 10 mm
deep, coupled to a position-sensitive photomultiplier tube.
The effective ®eld-of-view of each camera is about
45 mm £ 55 mm; an area generally suf®cient to image
most of the body of a mouse or body sections of rats. The
two scintillation cameras are rotated into a vertical orienta-
tion for projection imaging and the animal placed on a small
table midway between the detectors. The animal can be
injected while in the device and data acquisition started at
the same time so that the complete time-course of tracer
transit can be recorded.
The study portrayed in Fig. 2 was undertaken to deter-
mine the timing of the accumulation of F-18 labeled miso-
nidazole in the hypoxic cells of a RIF tumor xenograft
implanted in the animal's right thigh. The early images
(2A) show the transport of tracer through the heart, lungs
and liver while the later images show accumulation in the
bladder and in the tumor. The time-activity curve from the
tumor (2B) shows that 18-F continues to accumulate in the
tumor throughout the entire 2-h observation period. Activity
on the tumor-free control side, however, eventually declines
with time so that the ratio of tumor-to-tissue activity
increases. Together, these data suggest that quanti®cation
of tumor activity should be delayed beyond 2 h until the
tracer distribution becomes time-stationary. Such tracer-
speci®c timing information is essential if imaging
procedures are to be designed that will yield accurate and
reproducible estimates of a tumor's response to various
interventions.
6. Conclusions
Modern biomedical research offers numerous opportu-
nities for the use of nuclear medicine in vivo imaging tech-
niques to study small laboratory animals. PET, SPECT,
planar imaging and variants of these techniques permit
non-destructive assessment of functional changes in the
same animal over time, a capability of great value when
attempting to establish the ef®cacy of therapy or in estab-
lishing the functional consequences of a genetic manipula-
tion in a rare and expensive animal. In response to these
opportunities, advanced tracer imaging systems are being
developed with the goal of allowing the whole range of
human studies to be carried out in small animals with the
same relative acuity as in man. At present, the various tracer
imaging approaches in small animals are not equal in perfor-
mance or cost, so that each modality occupies only a portion
of the applications/cost spectrum. Moreover, no ªproduc-
tionº imaging system now exists that operates in the sub-
millimeter (or better) resolution range required to truly
extend these methods to the smallest, and perhaps most
important laboratory animal, the mouse. To alter this situa-
tion signi®cantly will require the solution of complex and
fundamental problems facing each of these modalities.
Despite these limitations, existing methods now offer the
biomedical scientist an unparalleled tool for studying the
physiology and biochemistry of living systems non-
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Fig. 2. (A) Six, 1 min duration anterior projection images of a tumor bear
ing mouse spaced at 20 min intervals following intravenous injection of
18 F misonidazole, a tracer that accumulates in hypoxic cells. (B) Tumor
time activity curve compared to a control region time activity curve from
the opposite thigh. The tumor continues to accumulate activity throughout
the observation period (2 h), while activity on the control side, after an
initial increase, slowly declines. This behavior suggests that quanti®cation
of misonidazole activity in the tumor be delayed beyond 2 h until tumor
activity becomes time stationary and background radioactivity is a small
fraction of the tumor activity.
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destructively [25]. With continued effort, these methods will
improve and very likely ®nd even wider application.
7. Summary
Developments in modern biomedical research have made
small laboratory animals, such as the mouse and rat, indis-
pensable to the advancement of medical research. Tools that
help the research scientist understand the biology, physiol-
ogy or biochemistry of these animals under varying condi-
tions in vivo are of potential importance in many areas,
including phenotype characterization of genetically-altered
animals, drug discovery and development and the assess-
ment of therapies in animal models of human disease. In
response to these opportunities, PET, SPECT and planar
imaging systems have been developed that provide an over-
lapping range of functional capabilities in small animals.
PET, the most technologically advanced method, can tomo-
graphically image regional static and dynamic tracer distri-
butions in animals the size of rats and whole organs in the
mouse. The next generation of ªproductionº PET imaging
systems will very likely exhibit millimeter (or better) spatial
resolution that will extend this technology to smaller
animals and improve performance in larger animals. Hybrid
positron imaging systems, e.g. PiPET, that offer substantial
functionality (high speed collimator-less positron projection
imaging and rotational PET) at low cost may also play a role
in introducing these methods to the research community.
SPECT and single photon projection imaging offer simi-
lar capabilities for tracers labeled with single photon emit-
ters like Tc-99m. Although SPECT is currently restricted to
imaging time-stationary ªmicrosphere-likeº tracers, many
such compounds have been developed including those that
visualize myocardial and cerebral blood ¯ow and other
important variables. Unlike PET, little research has been
done to create specialized SPECT instruments for small
animal imaging, though it is not dif®cult to imagine designs
with sensitivities much higher than single pinhole imaging.
Despite their limitations, existing methods already allow a
near endless variety of experiments to be carried out success-
fully in small animals provided care is taken to match the
right instrument and technique to the right experiment. With
continued technological re®nements and a growing sophis-
tication in applying these methods, small animal tracer
imaging could, in the not too distant future, become a
standard part of the biomedical research ªtool boxº.
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